The 2nd Generation VLTI path to performance

The upgrade of the VLTI infrastructure for the 2nd generation instruments is now complete with the transformation of the laboratory, and installation of star separators on both the 1.8-m Auxiliary Telescopes (ATs) and the 8-m Unit Telescopes (UTs). The Gravity fringe tracker has had a full semester of commissioning on the ATs, and a first look at the UTs. The CIAO infrared wavefront sensor is about to demonstrate its performance relative to the visible wavefront sensor MACAO. First astrometric measurements on the ATs and astrometric qualification of the UTs are on-going. Now is a good time to revisit the performance roadmap for VLTI that was initiated in 2014, which aimed at coherently driving the developments of the interferometer, and especially its performance, in support to the new generation of instruments: Gravity and MATISSE.Comment: 9 pages, 6 figures, 1 table, Proc. SPIE 201

Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis

Patient Acceptable Symptom State (PASS) is an absolute threshold proposed for symptomatic variables in osteoarthritis (OA) to determine the point beyond which patients consider themselves well and, as such, are satisfied with treatment. Two large previously reported studies of knee OA have shown that both lumiracoxib and celecoxib were superior to placebo in terms of conventional outcome measures. To assess the clinical relevance of these results from the patient's perspective, the same data pooled from these two studies were analysed with respect to the PASS. In total, 3,235 patients were included in two multicentre, randomised, double-blind studies of identical design. Patients were randomly assigned to receive lumiracoxib 100 mg once daily (n = 811), lumiracoxib 100 mg once daily with an initial dose of lumiracoxib 200 mg once daily for the first 2 weeks (100 mg once daily with initial dose [n = 805]), celecoxib 200 mg once daily (n = 813), or placebo (n = 806) for 13 weeks. Treatments were compared with respect to the PASS criteria (for OA pain, patient's global assessment of disease activity, and the Western Ontario and McMaster Universities Osteoarthritis Index Likert version 3.1 [WOMAC™ LK 3.1] Function [difficulty in performing daily activities] subscale score). At week 13, 43.3%, 45.3%, and 42.2% of patients in the lumiracoxib 100 mg once daily, lumiracoxib 100 mg once daily with initial dose, and the celecoxib 200 mg once daily groups, respectively, considered their current states as satisfactory versus 35.5% in the placebo group. Similar results were observed for patient's global assessment of disease activity and WOMAC™ LK 3.1 Function subscale score. This post hoc analysis suggests that the statistical significance of the results observed with lumiracoxib or celecoxib compared with placebo using conventional outcome variables is complemented by clinical relevance to the patient. Trial registration numbers: NCT00366938 and NCT00367315

DLX6 (distal-less homeobox 6)

DLX6 belongs to the six-member family of DLX genes characterized by a homeobox related to that found in the insect Distal-less (Dll) gene. The six DLX genes are organized as three bigenic pairs with a tail-to-tail orientation (Zerucha et al., 2000), and located on chromosomes where HOX clusters are also found (DLX5/DLX6; 7q21.3, syntenic to the HOXA cluster), (DLX1/DLX2; 2q32 syntenic to the HOXD cluster) and (DLX3/DLX4; 17q21.33 syntenic to the HOXB cluster). During embryonic development DLX genes are involved in the control of appendage and craniofacial morphogenesis and in the differentiation of reproductive organs; in the adult they play a role in bone homeostasis and in the maintenance of tissue integrity

Efficient CPP-mediated Cre protein delivery to developing and adult CNS tissues

<p>Abstract</p> <p>Background</p> <p>Understanding and manipulating gene function in physiological conditions is a major objective for both fundamental and applied research. In contrast to other experimental settings, which use either purely genetic or gene delivery (viral or non-viral) strategies, we report here a strategy based on direct protein delivery to central nervous system (CNS) tissues. We fused Cre recombinase with cell-penetrating peptides and analyzed the intracellular biological activity of the resulting chimerical proteins when delivered into cells endowed with Cre-mediated reporter gene expression.</p> <p>Results</p> <p>We show that active Cre enzymatic conjugates are readily internalized and exert their enzymatic activity in the nucleus of adherent cultured cells. We then evaluated this strategy in organotypic cultures of neural tissue explants derived from reporter mice carrying reporter "floxed" alleles. The efficacy of two protocols was compared on explants, either by direct addition of an overlying drop of protein conjugate or by implantation of conjugate-coated beads. In both cases, delivery of Cre recombinase resulted in genomic recombination that, with the bead protocol, was restricted to discrete areas of embryonic and adult neural tissues. Furthermore, delivery to adult brain tissue resulted in the transduction of mature postmitotic populations of neurons.</p> <p>Conclusion</p> <p>We provide tools for the spatially restricted genetic modification of cells in explant culture. This strategy allows to study lineage, migration, differentiation and death of neural cells. As a proof-of-concept applied to CNS tissue, direct delivery of Cre recombinase enabled the selective elimination of an interneuron subpopulation of the spinal cord, thereby providing a model to study early events of neurodegenerative processes. Thus our work opens new perspectives for both fundamental and applied cell targeting protocols using proteic cargoes which need to retain full bioactivity upon internalisation, as illustrated here with the oligomeric Cre recombinase.</p

DLX5 (distal-less homeobox 5)

DLX5 belongs to the six-member family of DLX genes characterized by a homeobox related to that found in the insect Distal-less (Dll) gene. The six DLX genes are organized as three bigenic pairs with a tail-to-tail orientation (Zerucha et al., 2000) and located on chromosomes where HOX clusters are also found (DLX5/DLX6; 7q21.3, syntenic to the HOXA cluster), (DLX1/DLX2; 2q32, syntenic to the HOXD cluster; Simeone et al., 1994) and (DLX3/DLX4; 17q21.33, syntenic to the HOXB cluster). During embryonic development DLX genes are involved in the control of appendage and craniofacial morphogenesis and in the differentiation of reproductive organs; in the adult they play a role in bone homeostasis and in the maintenance of tissue integrity

Investigation of the adaptation of Lactococcus lactis to isoleucine starvation integrating dynamic transcriptome and proteome information

Background: Amino acid assimilation is crucial for bacteria and this is particularly true for Lactic Acid Bacteria (LAB) that are generally auxotroph for amino acids. The global response of the Lmodel Lactococcus lactis ssp. lactis was characterized during progressive isoleucine starvation in batch culture using a chemically defined medium in which isoleucine concentration was fixed so as to become the sole limiting nutriment. Dynamic analyses were performed using transcriptomic and proteomic approaches and the results were analysed conjointly with fermentation kinetic data. Results: The response was first deduced from transcriptomic analysis and corroborated by proteomic results. It occurred progressively and could be divided into three major mechanisms: (i) a global down-regulation of processes linked to bacterial growth and catabolism (transcription, translation, carbon metabolism and transport, pyrimidine and fatty acid metabolism), (ii) a specific positive response related to the limiting nutrient (activation of pathways of carbon or nitrogen metabolism and leading to isoleucine supply) and (iii) an unexpected oxidative stress response (positive regulation of aerobic metabolism, electron transport, thioredoxin metabolism and pyruvate dehydrogenase). The involvement of various regulatory mechanisms during this adaptation was analysed on the basis of transcriptomic data comparisons. The global regulator CodY seemed specifically dedicated to the regulation of isoleucine supply. Other regulations were massively related to growth rate and stringent response. Conclusion: This integrative biology approach provided an overview of the metabolic pathways involved during isoleucine starvation and their regulations. It has extended significantly the physiological understanding of the metabolism of L. lactis ssp. lactis. The approach can be generalised to other conditions and will contribute significantly to the identification of the biological processes involved in complex regulatory networks of micro-organisms

Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231

<p>Abstract</p> <p>Background</p> <p>The <it>DLX </it>gene family encodes for homeobox transcription factors involved in the control of morphogenesis and tissue homeostasis. Their expression can be regulated by Endothelin1 (ET1), a peptide associated with breast cancer invasive phenotype. Deregulation of <it>DLX </it>gene expression was found in human solid tumors and hematologic malignancies. In particular, <it>DLX4 </it>overexpression represents a possible prognostic marker in ovarian cancer. We have investigated the role of <it>DLX </it>genes in human breast cancer progression.</p> <p>Methods</p> <p>MDA-MB-231 human breast carcinoma cells were grown in vitro or injected in nude mice, either subcutaneously, to mimic primary tumor growth, or intravenously, to mimic metastatic spreading. Expression of <it>DLX2</it>, <it>DLX5 </it>and <it>DLX6 </it>was assessed in cultured cells, either treated or not with ET1, tumors and metastases by RT-PCR. <it>In situ </it>hybridization was used to confirm <it>DLX </it>gene expression in primary tumors and in lung and bone metastases. The expression of <it>DLX2 </it>and <it>DLX5 </it>was evaluated in 408 primary human breast cancers examining the GSE1456 and GSE3494 microarray datasets. Kaplan-Meier estimates for disease-free survival were calculated for the patients grouped on the basis of <it>DLX2</it>/<it>DLX5 </it>expression.</p> <p>Results</p> <p>Before injection, or after subcutaneous growth, MDA-MB-231 cells expressed <it>DLX2 </it>but neither <it>DLX5 </it>nor <it>DLX6</it>. Instead, in bone and lung metastases resulting from intravenous injection we detected expression of <it>DLX5/6 </it>but not of <it>DLX2</it>, suggesting that <it>DLX5/6 </it>are activated during metastasis formation, and that their expression is alternative to that of <it>DLX2</it>. The <it>in vitro </it>treatment of MDA-MB-231 cells with ET1, resulted in switch from <it>DLX2 </it>to <it>DLX5 </it>expression. By data mining in microarray datasets we found that expression of <it>DLX2 </it>occurred in 21.6% of patients, and was significantly correlated with prolonged disease-free survival and reduced incidence of relapse. Instead, <it>DLX5 </it>was expressed in a small subset of cases, 2.2% of total, displaying reduced disease-free survival and high incidence of relapse which was, however, non-significantly different from the other groups due to the small size of the <it>DLX+ </it>cohort. In all cases, we found mutually exclusive expression of <it>DLX2 </it>and <it>DLX5</it>.</p> <p>Conclusions</p> <p>Our studies indicate that <it>DLX </it>genes are involved in human breast cancer progression, and that <it>DLX2 </it>and <it>DLX5 </it>genes might serve as prognostic markers.</p

Performance study of ground-based infrared Bracewell interferometers - Application to the detection of exozodiacal dust disks with GENIE

Nulling interferometry, a powerful technique for high-resolution imaging of the close neighbourhood of bright astrophysical objets, is currently considered for future space missions such as Darwin or the Terrestrial Planet Finder Interferometer (TPF-I), both aiming at Earth-like planet detection and characterization. Ground-based nulling interferometers are being studied for both technology demonstration and scientific preparation of the Darwin/TPF-I missions through a systematic survey of circumstellar dust disks around nearby stars. In this paper, we investigate the influence of atmospheric turbulence on the performance of ground-based nulling instruments, and deduce the major design guidelines for such instruments. End-to-end numerical simulations allow us to estimate the performance of the main subsystems and thereby the actual sensitivity of the nuller to faint exozodiacal disks. Particular attention is also given to the important question of stellar leakage calibration. This study is illustrated in the context of GENIE, the Ground-based European Nulling Interferometer Experiment, to be installed at the VLTI and working in the L' band. We estimate that this instrument will detect exozodiacal clouds as faint as about 50 times the Solar zodiacal cloud, thereby placing strong constraints on the acceptable targets for Darwin/TPF-I.Comment: A&A, accepte

Manufacturing and Installation of the Compound Cryogenic Distribution Line for the Large Hadron Collider

The Large Hadron Collider (LHC) [1] currently under construction at CERN will make use of superconducting magnets operating in superfluid helium below 2 K. A compound cryogenic distribution line (QRL) will feed with helium at different temperatures and pressures the local elementary cooling loops in the cryomagnet strings. Low heat inleak to all temperature levels is essential for the overall LHC cryogenic performance. Following a competitive tendering, CERN adjudicated in 2001 the contract for the series line to Air Liquide (France). This paper recalls the main features of the technical specification and shows the project status. The basic choices and achievements for the industrialization phase of the series production are also presented, as well as the installation issues and status

Ontology Domain Modeling Support for Multilingual Servicies in e-commerce: MKBEEM

One of the main objectives of a truly user-friendly Information Society is to focus on advanced human language technologies enabling cost-effective interchange across language and culture and more natural interfaces to digital services. The recently launched IST-1999-10589 project MKBEEM (Multilingual Knowledge Based European Electronic Marketplace, 1st Feb. 2000 - 1st Aug. 2002) is rightly in that direction and the work will address basically, written language technologies and its use in the key sector of global business and electronic commerce. In particular MKBEEM will focus on adding multilinguality to all stages of the information cycle, including multilingual content generation and maintenance, automated translation and interpretation and enhancing the natural interactivity and usability of the service with unconstrained language input. On the Knowledge engineering side, the MKBEEM Ontologies will provide a consensual representation of the electronic commerce field in three typical Domains (Tourism, Mail order, Retailers) allowing the exchanges independently of the language of the end user, the service, or the content provider. Ontologies will be used for classifying and indexing catalogues, for filtering user’s query, for facilitating multilingual man-machine dialogues between user and software agent, and for inferring information that is relevant to the user’s request. This paper concentrates on ontology issues, while the used human language processing approaches will be presented closely in our later papers